β¨ Medicines Distribution Consent
NEW ZEALAND GAZETTE, No. 115
9 SEPTEMBER 2010
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product:
Abilify
Active Ingredient:
Aripiprazole 2mg
Dosage Form:
Tablet
New Zealand Sponsor:
Bristol-Myers Squibb (NZ) Limited
Manufacturers:
Otsuka Pharmaceutical Co Limited, Tokushima, Japan
Bristol-Myers Squibb Manufacturing Company, Mayaguez, Puerto Rico
Bristol-Myers Squibb Manufacturing Company, Humacao, Puerto Rico
Product:
Abilify
Active Ingredient:
Aripiprazole 5mg
Dosage Form:
Tablet
New Zealand Sponsor:
Bristol-Myers Squibb (NZ) Limited
Manufacturers:
Otsuka Pharmaceutical Co Limited, Tokushima, Japan
Bristol-Myers Squibb Manufacturing Company, Mayaguez, Puerto Rico
Bristol-Myers Squibb Manufacturing Company, Humacao, Puerto Rico
Product:
Abilify
Active Ingredient:
Aripiprazole 10mg
Dosage Form:
Tablet
New Zealand Sponsor:
Bristol-Myers Squibb (NZ) Limited
Manufacturers:
Otsuka Pharmaceutical Co Limited, Tokushima, Japan
Bristol-Myers Squibb Manufacturing Company, Mayaguez, Puerto Rico
Bristol-Myers Squibb Manufacturing Company, Humacao, Puerto Rico
Product:
Abilify
Active Ingredient:
Aripiprazole 15mg
Dosage Form:
Tablet
New Zealand Sponsor:
Bristol-Myers Squibb (NZ) Limited
Manufacturers:
Otsuka Pharmaceutical Co Limited, Tokushima, Japan
Bristol-Myers Squibb Manufacturing Company, Mayaguez, Puerto Rico
Bristol-Myers Squibb Manufacturing Company, Humacao, Puerto Rico
Product:
Abilify
Active Ingredient:
Aripiprazole 20mg
Dosage Form:
Tablet
New Zealand Sponsor:
Bristol-Myers Squibb (NZ) Limited
Manufacturers:
Otsuka Pharmaceutical Co Limited, Tokushima, Japan
Bristol-Myers Squibb Manufacturing Company, Mayaguez, Puerto Rico
Bristol-Myers Squibb Manufacturing Company, Humacao, Puerto Rico
Product:
Abilify
Active Ingredient:
Aripiprazole 30mg
Dosage Form:
Tablet
New Zealand Sponsor:
Bristol-Myers Squibb (NZ) Limited
Manufacturers:
Otsuka Pharmaceutical Co Limited, Tokushima, Japan
Bristol-Myers Squibb Manufacturing Company, Mayaguez, Puerto Rico
Bristol-Myers Squibb Manufacturing Company, Humacao, Puerto Rico
Product:
Abilify ODT
Active Ingredient:
Aripiprazole 10mg
Dosage Form:
Orodispersible tablet
New Zealand Sponsor:
Bristol-Myers Squibb (NZ) Limited
Manufacturer:
Bristol-Myers Squibb Manufacturing Company, Mayaguez, Puerto Rico
Product:
Abilify ODT
Active Ingredient:
Aripiprazole 15mg
Dosage Form:
Orodispersible tablet
New Zealand Sponsor:
Bristol-Myers Squibb (NZ) Limited
Manufacturer:
Bristol-Myers Squibb Manufacturing Company, Mayaguez, Puerto Rico
Next Page →
β¨ LLM interpretation of page content
π₯
Consent to the Distribution of New Medicines
(continued from previous page)
π₯ Health & Social Welfare9 September 2010
Medicines, Distribution, Abilify, Aripiprazole
NZ Gazette 2010, No 115